CELU
Celularity Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.71
−6.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 1.25x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.30x
- Price / sales
- 1.86x
- Price / cash flow
- -3.73x
Enterprise value
- Enterprise value
- $84.2M
- EV / sales
- 3.17x
- EV / EBITDA
- -1.09x
- EV / EBIT
- -1.37x
- Market cap
- $49.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025